Drug recall · September 23, 2015
Cevimeline Hydrochloride Capsules recall
Why: Failed Stability Specifications: product may not meet specification limit for assay test.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Cevimeline Hydrochloride Capsules, 30 mg a) 100 count bottle, and b) 500 count bottle, Rx Only, Manufactured by: Apotex Research Pvt., Ltd., Bangalore, India, Manufactured for: Apotex Corp, Westin, FL, a) NDC 60505-3145-1, b) NDC 60505-3145-5
- Lots / codes
Lot #s: a) KP9749, KT3501, Exp 09/2015, KP4524, Exp 11/2015, KV8264, Exp 01/2016, KX8713, KX8714, KX8715, Exp 04/2016; b) KP4525, Exp 11/2015, KP9750, Exp 12/2015, KX8716, Exp 04/2016
- Quantity
- 117,644 Bottles
- Company
- Apotex Inc., Toronto
- Distribution
- Nationwide and Puerto Rico
- Initiated
- August 17, 2015 · Voluntary: Firm initiated
- Classified
- September 15, 2015
- Reported
- September 23, 2015
- Ended
- June 15, 2022
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Cevimeline
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.